Therapy insight: heart disease and the insulin-resistant patient. (Q30351748)

20 June 2017

1 reference

title

Therapy insight: heart disease and the insulin-resistant patient. (English)

1 reference

20 June 2017

1 reference

Stuart A Cook

1

1 reference

20 June 2017

Tim Aitman

series ordinal

2

1 reference

20 June 2017

Rossi P Naoumova

series ordinal

3

1 reference

20 June 2017

publication date

1 May 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

20 June 2017

published in

1 reference

20 June 2017

volume

2

1 reference

20 June 2017

issue

5

1 reference

20 June 2017

page(s)

252-260

1 reference

Global and societal implications of the diabetes epidemic

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Diabetes and other coronary heart disease risk equivalents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Influence of diabetes mellitus on heart failure risk and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

New type of cardiomyopathy associated with diabetic glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Treatment of dyslipoproteinemia in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Existing and investigational combination drug therapy for high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Revascularisation in diabetics with multivessel coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Managing the patient with diabetes mellitus and heart failure: issues and considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Cellular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Major Gene Effect for Insulin Levels in Familial NIDDM Pedigrees

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Genetics of familial combined hyperlipidemia and risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Molecular genetics of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Strategies and prospects for finding insulin resistance genes

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

The association between glucose abnormalities and heart failure in the population-based Reykjavik study

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Peroxisome proliferator-activated receptor alpha,gamma coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1038/NCPCARDIO0194

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0194

1 reference

20 June 2017

1 reference